MedPath
NMPA Approval

Salmeterol Xinafoate and Fluticasone Propionate Powder for Inhalation

H20150323

February 4, 2020

H20150323

Drug Information

沙美特罗替卡松吸入粉雾剂

舒利迭

舒利迭

吸入粉雾剂

每泡含昔萘酸沙美特罗50μg(按C₂₅H₃₇NO₄计)与丙酸氟替卡松100μg,递送剂量为昔萘酸沙美特罗47µg(按C₂₅H₃₇NO₄计)与丙酸氟替卡松92µg

化学药品

February 4, 2020

February 3, 2025

Company Information

Applicant Company

23 rue Francois Jacob, 92500 RUEIL-MALMAISON, FRANCE

Manufacturing Company

Zone Industrielle n° 2, 23 rue Lavoisier, 27000 Evreux, France

© Copyright 2025. All Rights Reserved by MedPath